Clinical research sponsors continue to outsource the management of their clinical trials, spending millions of dollars for a pivotal phase and significant risk medical device trial. Choosing a clinical research organization with compliance expertise will protect your investment and ensure your product is ultimately approved.
The right CRO should understand their important role as a partner in compliance who shares your commitment to protect human subjects and ensure data integrity. They should collaborate with your team and offer strategic recommendations that mitigate risk and streamline your process, rather than slowing it down.
IMARC has created a new whitepaper that outlines what this looks like in practice, including what a compliance-minded CRO should deliver. The paper is based on our experiences and successes from the past two decades and is a helpful guide for anyone seeking to outsource the management of their clinical trial.